Palvella Therapeutics Inc
Palvella Therapeutics Inc (PVLA) Expected Move
PVLA expected move through Oct 16, 2026 is 10.2%, with 21 days to expiration. The implied range is $131.14 to $161.00, based on the previous trading day's options prices.
Read more
Tracking the PVLA expected move helps you see how far Palvella Therapeutics Inc's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Palvella Therapeutics Inc's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the PVLA expected move for this week's options, in real time.
The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For PVLA, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The PVLA expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Palvella Therapeutics Inc is unlikely to go.
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. Its lead product candidate is QTORIN 3.9% rapamycin anhydrous gel (QTORIN rapamycin) that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania.
Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the PVLA expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Palvella Therapeutics Inc expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about PVLA.
PVLA Price
Drag chart to pan. Drag axes to zoom.
| Expiration | DTE | Expected move (USD) | Expected move (%) | Upper price | Lower price |
|---|---|---|---|---|---|
| Oct 16, 2026 | 21 | $14.93 | 10.2% | $161.00 | $131.14 |
| Nov 20, 2026 | 56 | $24.65 | 16.9% | $170.72 | $121.42 |
| Feb 19, 2027 | 147 | $40.18 | 27.5% | $186.25 | $105.90 |
| May 21, 2027 | 238 | $52.43 | 35.9% | $198.50 | $93.65 |
As of September 23, 2026
Know What the Market Expects From PVLA
Track the PVLA expected move across every expiration, filter by IV rank and liquidity, and trade around the range the market is already pricing in.
Start your 14-day free trial→